What Is New - Paediatric Rheumatological Conditions

Take a look at our 'What is new' highlights in paediatric rheumatology!

May 2022

"Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA"

Why WIN?

This large analysis of real-world data, including >8000 children and young people with JIA, identified that the risk of new onset TNF inhibitor-associated psoriasis was ~5.6 times higher (adjusted for methotrexate, sex, race, family history of psoriasis, and ILAR) in those with non-psoriatic arthritis compared with those not treated with TNF inhibitors.

Interactive question

Would you be more likely to report new-onset psoriasis in JIA for those on TNFi – could this higher rate be influenced by reporting bias?

Yes/ No

Join the discussion on twitter... Share your response with us using the hastag  #WhatIsNew and tag us @EMEUNET

December 2021

November 2021

October 2021

January 2021

December 2020

November 2020

October 2020

September 2020

February 2020

January 2020

December 2019

November 2019

September 2019

August 2019

July 2019

June 2019

May 2019

April 2019

March 2019

February 2019

January 2019

December 2018

November 2018

October 2018

September 2018

Click here to be directed to the article by Cann et al (2018).

August 2018

Childhood-onset rheumatic diseases / Bone health

Click here to be directed to the article by Inoue et al (2018).

July 2018

Juvenile localised scleroderma

Click here to be directed to the article by Agazzi et al (2018).

June 2018

Kawasaki Disease

Click here to be directed to the article by Zhang et al (2018).

May 2018

Juvenile myositis

Click here to be directed to the article by Yeker et al (2018).

April 2018

Juvenile idiopathic arthritis

Click here to be directed to the article by Höfel et al (2018).